Corruption in Anglophone West Africa health systems: a systematic review of its different variants and the factors that sustain them.

African health systems Anglophone West Africa Health sector health sector corruption universal health coverage

Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
01 Sep 2019
Historique:
accepted: 01 07 2019
pubmed: 5 8 2019
medline: 20 2 2020
entrez: 5 8 2019
Statut: ppublish

Résumé

West African countries are ranked especially low in global corruption perception indexes. The health sector is often singled out for particular concern given the role of corruption in hampering access to, and utilization of health services, representing a major barrier to progress to universal health coverage and to achieving the health-related Sustainable Development Goals. The first step in tackling corruption systematically is to understand its scale and nature. We present a systematic review of literature that explores corruption involving front-line healthcare providers, their managers and other stakeholders in health sectors in the five Anglophone West African (AWA) countries: Gambia, Ghana, Liberia, Nigeria and Sierra Leone, identifying motivators and drivers of corrupt practices and interventions that have been adopted or proposed. Boolean operators were adopted to optimize search outputs and identify relevant studies. Both grey and published literature were identified from Research Gate, Yahoo, Google Scholar, Google and PubMed, and reviewed and synthesized around key domains, with 61 publications meeting our inclusion criteria. The top five most prevalent/frequently reported corrupt practices were (1) absenteeism; (2) diversion of patients to private facilities; (3) inappropriate procurement; (4) informal payments; and (5) theft of drugs and supplies. Incentives for corrupt practices and other manifestations of corruption in the AWA health sector were also highlighted, while poor working conditions and low wages fuel malpractice. Primary research on anti-corruption strategies in health sectors in AWA remains scarce, with recommendations to curb corrupt practices often drawn from personal views and experience rather that of rigorous studies. We argue that a nuanced understanding of all types of corruption and their impacts is an important precondition to designing viable contextually appropriate anti-corruption strategies. It is a particular challenge to identify and tackle corruption in settings where formal rules are fluid or insufficiently enforced.

Identifiants

pubmed: 31377775
pii: 5543565
doi: 10.1093/heapol/czz070
pmc: PMC6788210
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Pagination

529-543

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine.

Références

Glob Soc Policy. 2015 Dec;15(3):345-348
pubmed: 26635505
BMC Med. 2016 Sep 29;14(1):149
pubmed: 27680102
Int Health. 2015 Nov;7(6):400-4
pubmed: 25908714
Soc Sci Med. 2016 Feb;151:173-86
pubmed: 26808336
BMC Health Serv Res. 2013 Oct 04;13:387
pubmed: 24093219
J Glob Health. 2016 Dec;6(2):020408
pubmed: 27648255
Health Policy. 2010 Jun;96(1):72-9
pubmed: 20116125
Int J Health Plann Manage. 2004 Apr-Jun;19(2):163-78
pubmed: 15239210
Health Policy Plan. 2011 Jul;26 Suppl 1:i45-52
pubmed: 21729917
Soc Sci Med. 2005 Apr;60(7):1445-57
pubmed: 15652678
Cochrane Database Syst Rev. 2016 Aug 16;(8):CD008856
pubmed: 27528494
Lancet. 2016 Aug 20;388(10046):757
pubmed: 27560272
Global Health. 2009 Oct 29;5:14
pubmed: 19874613
J Public Econ. 2017 Dec;156:150-169
pubmed: 29576663
PLoS One. 2014 Apr 11;9(4):e93887
pubmed: 24728103
Health Policy Plan. 2008 Mar;23(2):83-94
pubmed: 18281310
Health Policy Plan. 2008 Mar;23(2):150-60
pubmed: 18245803

Auteurs

Obinna Onwujekwe (O)

Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu-Campus, Enugu, Nigeria.
Department of Health Administration and Management, University of Nigeria, Enugu-Campus, Enugu, Nigeria.

Prince Agwu (P)

Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu-Campus, Enugu, Nigeria.
Department of Social Work, University of Nigeria, Nsukka, Nigeria.

Charles Orjiakor (C)

Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu-Campus, Enugu, Nigeria.
Department of Psychology, University of Nigeria, Nsukka, Nigeria.

Martin McKee (M)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.

Eleanor Hutchinson (E)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.

Chinyere Mbachu (C)

Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu-Campus, Enugu, Nigeria.
Department of Community Medicine, College of Medicine, University of Nigeria, Enugu-Campus, Enugu, Nigeria.

Aloysius Odii (A)

Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu-Campus, Enugu, Nigeria.
Department of Sociology, University of Nigeria, Nsukka, Nigeria.

Pamela Ogbozor (P)

Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu-Campus, Enugu, Nigeria.

Uche Obi (U)

Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu-Campus, Enugu, Nigeria.
Department of Community Medicine, College of Medicine, University of Nigeria, Enugu-Campus, Enugu, Nigeria.

Hyacinth Ichoku (H)

Health Policy Research Group, Department of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu-Campus, Enugu, Nigeria.
Department of Economics, University of Nigeria, Nsukka, Nigeria.

Dina Balabanova (D)

Department of Global Health and Development, London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH